IP Library › Assignment 052232/0474
Patent Assignment
Reel/Frame 052232/0474

Change of Name

Recorded: 2020-03-26 Pages: 9
Assignor
GLENMARK PHARMACEUTICALS S.A.
Executed: 2019-12-17
Assignee
ICHNOS SCIENCES SA
CHEMIN DE LA COMBETA 5, LA CHAUX-DE-FONDS, 2300, SWITZERLAND
Covered Properties (9)
TRIAZOLONE COMPOUNDS AS mPGES-1 INHIBITORS
Patent: 9,096,545 →
Application: 14/123,409 →
Publication: US 2015/0087646
Triazolone Compounds as Mpges-1 Inhibitors
Patent: 9,439,890 →
Application: 14/745,204 →
Publication: US 2015/0283117
Triazolone Compounds as Mpges-1 Inhibitors
Patent: 9,949,955 →
Application: 15/228,681 →
Publication: US 2016/0339000
POLYMORPHS OF A mPGES-1 INHIBITING TRIAZOLONE COMPOUND
Application: 15/573,387 →
Publication: US 2018/0134671
Triazolone Compounds as Mpges-1 Inhibitors
Application: 15/919,460 →
Publication: US 2018/0200229
POLYMORPHS OF A mPGES-1 INHIBITING TRIAZOLONE COMPOUND
Application: 16/119,306 →
Publication: US 2018/0370923
mPGES-1 INHIBITOR FOR THE TREATMENT OF OSTEOARTHRITIS PAIN
Application: 16/282,125 →
Publication: US 2019/0175562
Triazolone Compounds as Mpges-1 Inhibitors
Application: 16/423,992 →
Publication: US 2019/0282548
NANOPARTICULATE FORMULATION COMPRISING AN mPGES-1 INHIBITOR
Application: 16/527,817 →
Publication: US 2020/0197370
Related Assignments (3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 29, 2014
From: GHARAT, LAXMIKANT A; MUTHUKAMAN, NAGARAJAN; KHAIRATKAR-JOSHI, NEELIMA; KATTIGE, VIDYA G
To: GLENMARK PHARMACEUTICALS S.A.
Reel/Frame 034593/0108 →
Assignment of Assignor's Interest Dec 6, 2017
From: MUTHUKAMAN, NAGARAJAN; GHARAT, LAXMIKANT A; KADAM, SURESH M; GAVHANE, SACHIN
To: GLENMARK PHARMACEUTICALS S.A.
Reel/Frame 044317/0053 →
Assignment of Assignor's Interest Mar 27, 2019
From: TANDON, MONIKA; SANT, SUMIT; KHAIRATKAR-JOSHI, NEELIMA; GUDI, GIRISH
To: GLENMARK PHARMACEUTICALS S.A.
Reel/Frame 048716/0348 →